Home > Available Issues
Special Article
Treatment Guidelines for Community-acquired Pneumonia in Korea: An Evidence-based Approach to Appropriate Antimicrobial Therapy
Jae-Hoon Song, M.D.1*, Ki-Suck Jung, M.D.2*, Moon Won Kang, M.D.3, Do Jin Kim4, Hyunjoo Pai, M.D.5, Gee Young Suh, M.D.1, Tae Sun Shim, M.D.6, Joong Hyun Ahn7, Chul Min Ahn8, Jun Hee Woo, M.D.6, Nam Yong Lee, M.D.1, Dong-Gun Lee, M.D.3, Mi Suk Lee, M.D.9, Sang Moo Lee10, Yeong Seon Lee, Ph.D.11, Hyukmin Lee, M.D.12, Doo Ryeon Chung, M.D.1; a Joint committee for CAP Treatment Guideline
Samsung Medical Center, Sungkyunkwan University School of Medicine1, Hallym University Sacred Heart Hospital2, Seoul St. Marys Hospital, College of Medicine, The Catholic University of Korea3, Soonchunhyang University Bucheon Hospital4, Hanyang University Hospital5, University of Ulsan College of Medicine, Asan Medical Cetner6, Incheon St. Marys Hospital, College of Medicine, The Catholic University of Korea7, Gangnam Severance Hospital, Yonsei University College of Medicine8, Kyung Hee University Medical Center, Kyung Hee University School of Medicine9, Health Insurance Review & Assessment Service10, Korea Centers for Disease Control and Prevention11, Kwandong University Myongji Hospital12, Korea
Vol.41 Num.3 (p133~153)
A successful therapy of community-acquired pneumonia requires appropriate empirical antimicrobial therapy. Etiology and antimicrobial susceptibility of major pathogens of pneumonia can differ by country. Therefore, an ideal treatment guideline of community-acquired pneumonia should be based on the studies performed in each country. We developed a treatment guideline for community-acquired pneumonia in immunocompetent adults in Korea. This guideline was developed by the joint committee of the Korean Society for Chemotherapy, the Korean Society of Infectious Diseases, and the Korean Academy of Tuberculosis and Respiratory diseases.
Keywords : Pneumonia, Community-acquired infections, Guideline